Jun 8, 2026 06:55AM
May 7, 2026 07:00AM
May 5, 2026 07:01AM
Apr 28, 2026 12:18PM
Apr 28, 2026 06:35AM
Mar 25, 2026 06:57AM
Mar 19, 2026 06:12AM Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $30 at Guggenheim
Mar 5, 2026 06:51AM
Mar 3, 2026 08:05AM
Mar 3, 2026 07:00AM
Mar 2, 2026 04:06PM
Feb 10, 2026 06:52AM
Jan 8, 2026 01:32PM
Jan 2, 2026 10:00PM Here are Mizuho's top Biotech pick for 2026
Dec 19, 2025 09:06AM
Dec 5, 2025 09:00AM
Nov 10, 2025 06:49AM
Nov 6, 2025 07:03AM
Nov 4, 2025 07:45AM
Oct 28, 2025 08:27AM
Oct 21, 2025 10:53AM Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX): Grabar Law Office is Investigating Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss
Oct 15, 2025 08:50AM
Oct 10, 2025 11:08AM
Oct 7, 2025 03:12PM
Oct 3, 2025 05:05AM
Sep 15, 2025 07:24AM
Aug 27, 2025 01:15PM
Aug 27, 2025 07:05AM Amylyx discontinues AMX0035 trial for progressive supranuclear palsy
Aug 27, 2025 05:40AM
Aug 7, 2025 07:00AM
Jul 14, 2025 03:41PM
Jul 14, 2025 08:19AM
Jul 10, 2025 02:23AM
Jun 24, 2025 06:09AM
Jun 17, 2025 05:17AM Citi Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
Jun 11, 2025 06:37AM
Jun 3, 2025 07:01AM
May 30, 2025 05:31AM
May 12, 2025 07:01AM
May 12, 2025 06:58AM
May 8, 2025 07:01AM
Apr 30, 2025 07:03AM Amylyx Pharmaceuticals (AMLX) Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
Apr 7, 2025 05:32AM
Mar 4, 2025 07:32AM
Mar 4, 2025 06:00AM
Jan 21, 2025 09:00AM
Jan 10, 2025 08:27AM
Dec 6, 2024 06:48AM
Dec 4, 2024 07:32AM Amylyx Pharmaceuticals (AMLX) Announces Pivotal Phase 3 LUCIDITY Trial Design for Avexitide
Nov 21, 2024 05:09AM

416,806 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All